Clinical Trial Update: Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing budesonide effervescent tablets, budesonide viscous suspension, and placebo in eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Budesonide effervescent tablets (budesonide)
• Budesonide viscous suspension (budesonide)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED